Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × Chemoradiotherapy × 90 days × Clear all

Sponsor

Conditions

Rectal Neoplasms 5 Oropharyngeal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Pathologic Complete Response 2 Mouth Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Thymoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1 Resectable Esophageal Cancer 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pancreatic Cancer Non-resectable 1 Nasopharyngeal Carcinoma 1 Laryngeal Neoplasms 1 Infiltrating Bladder Urothelial Carcinoma 1 Hypopharyngeal Neoplasms 1 HPV-Related Squamous Cell Carcinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Fluorouracil 10 Oxaliplatin 9 Nivolumab 9 Leucovorin 8 Capecitabine 7 pembrolizumab 4 Trastuzumab 4 Paclitaxel 4 Cisplatin 4 Specimen Handling 3 Irinotecan 3 Docetaxel 3 zimberelimab 2 zanidatamab 2 durvalumab 2 dehydroftorafur 2 Taxes 2 Radiotherapy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Endoscopy 2 Drug Therapy 2 Carboplatin 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 tremelimumab 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡